Synthetic Biology's Defense Dollars: Signals and Perceptions
By Dr. Filippa Lentzos,
PLOS Blogs
| 12. 24. 2015
Untitled Document
Synthetic biology is swimming in defense dollars. The most recent figures available on US trends in synthetic biology research funding indicate that two thirds of the $200 million invested in 2014 came from the Department of Defense or its research agency DARPA. While many scientists see military money as just another source of funding on par with NIH or NSF funding—after all, the majority of the funds are for basic science without security classification and publication restrictions—there are good reasons not to brush it off. One of these is the perception of the field to outsiders.
From an international security perspective, the extensive influx of military funding can be perceived as threatening to analysts in other countries following these developments. The US Department of Defense declared just over $655 million on national biodefence research in 2014. Synthetic biology research appears, therefore, to make up about a fifth of the biodefence budget. DARPA aims not only to develop radically new, game-changing technologies for national security in order to maintain US technological supremacy, it also aims to create technological surprise...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...